Breaking News, Financial News

Financial Report: AMRI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 2Q Revenues: $49.4 million (+8%) 2Q Earnings: $4.6 million (loss of $353,000 in 2Q2006)* YTD Revenues: $97.7 million (+10%) YTD Earnings: $7.8 million (earnings were $1.5 million YTD2006) Comments: Contract revenue in the quarter was $39.9 million, up 4%. Contract revenue from development and small-scale manufacturing was $10.6 million, up 25%, while large-scale manufacturing revenue was down 5% to $19.6 million. Revenue from discovery services in the quarter was $9.7 ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters